Last reviewed · How we verify

nighttime cramps in calves — Treatment Landscape & Competitive Intelligence

nighttime cramps in calves (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating nighttime cramps in calves, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Arnicare Leg Cramps COPPER Sebela Womens Hlth Copper-containing Intrauterine Device [EPC] 2026-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Sebela Womens Hlth · 1 drug in nighttime cramps in calves

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in nighttime cramps in calves:

Cite this brief

Drug Landscape (2026). nighttime cramps in calves — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/nighttime-cramps-in-calves. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing